# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-024666
Filing Date
2025-05-12
Accepted
2025-05-12 16:07:46
Documents
96
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | arwr-20250331.htm iXBRL | 10-Q | 1303843
2 | EX-10.1 | ceoseveranceandchangeofcon.htm | EX-10.1 | 104565
3 | EX-10.2 | cfoseveranceandchangeofcon.htm | EX-10.2 | 101303
4 | EX-10.3 | severanceandchangeofcontro.htm | EX-10.3 | 101565
5 | EX-10.4 | cmoseveranceandchangeofcon.htm | EX-10.4 | 101520
6 | EX-10.5 | retirementletteragreement-.htm | EX-10.5 | 6675
7 | EX-31.1 | arwr-03312025xexx311.htm | EX-31.1 | 9731
8 | EX-31.2 | arwr-03312025xexx312.htm | EX-31.2 | 9729
9 | EX-32.1 | arwr-03312025xexx321.htm | EX-32.1 | 4303
10 | EX-32.2 | arwr-03312025xexx322.htm | EX-32.2 | 3879
16 | GRAPHIC | image_0a.jpg | GRAPHIC | 17309
| Complete submission text file | 0001628280-25-024666.txt |  | 8678791

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | arwr-20250331.xsd | EX-101.SCH | 66706
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | arwr-20250331_cal.xml | EX-101.CAL | 87974
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | arwr-20250331_def.xml | EX-101.DEF | 309477
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | arwr-20250331_lab.xml | EX-101.LAB | 721836
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | arwr-20250331_pre.xml | EX-101.PRE | 557062
99 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-20250331_htm.xml | XML | 1180938

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 25934812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)